GR3006536T3 - - Google Patents
Info
- Publication number
- GR3006536T3 GR3006536T3 GR920402910T GR920402910T GR3006536T3 GR 3006536 T3 GR3006536 T3 GR 3006536T3 GR 920402910 T GR920402910 T GR 920402910T GR 920402910 T GR920402910 T GR 920402910T GR 3006536 T3 GR3006536 T3 GR 3006536T3
- Authority
- GR
- Greece
- Prior art keywords
- igm
- antibodies
- less
- nucleic acid
- acid content
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 abstract 1
- 238000004255 ion exchange chromatography Methods 0.000 abstract 1
- 238000001542 size-exclusion chromatography Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Detergent Compositions (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8313687A | 1987-08-10 | 1987-08-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3006536T3 true GR3006536T3 (enExample) | 1993-06-30 |
Family
ID=22176414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR920402910T GR3006536T3 (enExample) | 1987-08-10 | 1992-12-14 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0303088B1 (enExample) |
| JP (1) | JP2730913B2 (enExample) |
| AT (1) | ATE82136T1 (enExample) |
| AU (1) | AU618745B2 (enExample) |
| CA (1) | CA1341474C (enExample) |
| DE (1) | DE3875852T2 (enExample) |
| ES (1) | ES2045027T3 (enExample) |
| GR (1) | GR3006536T3 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01197500A (ja) * | 1988-01-29 | 1989-08-09 | Sumitomo Chem Co Ltd | ヒトモノクローナル抗体 |
| DE3825429C2 (de) * | 1988-07-27 | 1994-02-10 | Biotest Pharma Gmbh | Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt |
| EP0382031A3 (en) * | 1989-02-10 | 1991-06-26 | Miles Inc. | Monoclonal antibodies in immune serum globulin |
| CA2049342A1 (en) * | 1989-03-27 | 1990-09-28 | Sally Bolmer | Formulations for stabilizing of igm antibodies |
| HUT63343A (en) * | 1990-07-03 | 1993-08-30 | Akzo Nv | Process for producing immunereactive compounds |
| JPH0565233A (ja) * | 1991-03-08 | 1993-03-19 | Mitsui Toatsu Chem Inc | モノクローナル抗体含有凍結乾燥製剤 |
| EP0852951A1 (de) | 1996-11-19 | 1998-07-15 | Roche Diagnostics GmbH | Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern |
| ATE414537T1 (de) | 2001-08-29 | 2008-12-15 | Chugai Pharmaceutical Co Ltd | Antikörper enthaltende stabilisierte zubereitungen |
| EP1652925B1 (en) | 2003-07-15 | 2010-12-08 | Chugai Seiyaku Kabushiki Kaisha | IgM PRODUCTION BY TRANSFORMED CELLS AND METHODS FOR QUANTIFYING SAID IgM PRODUCTION |
| JP4762717B2 (ja) * | 2003-10-09 | 2011-08-31 | 中外製薬株式会社 | ＩｇＭ高濃度安定化溶液 |
| JP4671864B2 (ja) | 2003-10-09 | 2011-04-20 | 中外製薬株式会社 | タンパク質溶液の安定化方法 |
| CA2788527A1 (en) * | 2010-01-29 | 2011-08-04 | Axis Inc. | Pharmaceutical composition for osteoarthritis treatment or prevention and manufacturing method therefor |
| US10570194B2 (en) | 2015-08-06 | 2020-02-25 | Grifols Worldwide Operations Limited | Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM) |
| US20240417445A1 (en) * | 2023-06-13 | 2024-12-19 | Grifols Worldwide Operations Limited | Method for producing a lyophilized composition comprising polyclonal igm and composition obtained |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4604235A (en) * | 1984-05-23 | 1986-08-05 | J. T. Baker Chemical Company | Purification of monoclonal antibodies |
| US4834975A (en) * | 1984-05-25 | 1989-05-30 | Genetics Corporation | Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production |
| JPH0669961B2 (ja) * | 1984-09-25 | 1994-09-07 | 株式会社ミドリ十字 | 免疫グロブリンの加熱処理方法 |
-
1988
- 1988-07-25 AT AT88111931T patent/ATE82136T1/de not_active IP Right Cessation
- 1988-07-25 ES ES88111931T patent/ES2045027T3/es not_active Expired - Lifetime
- 1988-07-25 EP EP88111931A patent/EP0303088B1/en not_active Expired - Lifetime
- 1988-07-25 DE DE8888111931T patent/DE3875852T2/de not_active Expired - Lifetime
- 1988-08-02 AU AU20315/88A patent/AU618745B2/en not_active Expired
- 1988-08-09 CA CA000574199A patent/CA1341474C/en not_active Expired - Fee Related
- 1988-08-09 JP JP63197281A patent/JP2730913B2/ja not_active Expired - Lifetime
-
1992
- 1992-12-14 GR GR920402910T patent/GR3006536T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0303088A3 (en) | 1989-05-17 |
| CA1341474C (en) | 2005-03-08 |
| JP2730913B2 (ja) | 1998-03-25 |
| ES2045027T3 (es) | 1994-01-16 |
| EP0303088A2 (en) | 1989-02-15 |
| DE3875852T2 (de) | 1993-03-18 |
| AU2031588A (en) | 1989-06-08 |
| DE3875852D1 (de) | 1992-12-17 |
| AU618745B2 (en) | 1992-01-09 |
| EP0303088B1 (en) | 1992-11-11 |
| ATE82136T1 (de) | 1992-11-15 |
| JPH02493A (ja) | 1990-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3006536T3 (enExample) | ||
| TW427905B (en) | Aqueous pharmaceutical composition of nerve growth factor | |
| AU590896B2 (en) | Improved formulations for recombinant beta-interferon | |
| AU6323686A (en) | Monoclonal antibodies binding determinants of gram negative bacteria | |
| EP0345549A3 (en) | Removal of protein a from antibody preparations | |
| AU7256987A (en) | Method of affinity purification employing monoclonal antibodies | |
| EP0282317A3 (en) | Purified platelet-derived growth factor and methods for purification thereof | |
| FR2432038A1 (fr) | Conjugues marques d'hydrazide d'acide naphtalene-1,2-dicarboxylique chimioluminescent et leur procede de preparation | |
| AU592952B2 (en) | Monoclonal antibody stabilization | |
| AU6036690A (en) | Human monoclonal antibodies to hiv-1mn gp 120 | |
| FR2590172B1 (fr) | Nouvel antigene commun (psc-a) de pseudomonas aeruginosa protegeant contre l'infection provoquee par cet organisme | |
| AU7495887A (en) | Monoclonal antibodies to pseudomonas aeruginosa flagella | |
| AU2518688A (en) | A hybridoma producing a monoclonal antibody | |
| TW287200B (enExample) | ||
| AU3718784A (en) | Antibodies and antibody containing compositions for inhibiting gingivitis | |
| IL99263A0 (en) | Process for the preparation of crystalline taca | |
| AU7649187A (en) | Preparation of monoclonal antibodies | |
| AU568694B2 (en) | N-benzyl-n-phenyl-b-pyrrolidinyl-f-isobutoxy-propylamine | |
| ATE76082T1 (de) | Reinigungsmethode fuer antikoerper. | |
| EP0502553A3 (en) | Peptide fragment from human villin and antibody thereto | |
| AU1550783A (en) | Method of affinity purification employing monoclonal antibodies | |
| AU5675790A (en) | Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria | |
| EP0302503A3 (en) | Method for the separation and purification of t-pa | |
| AU2816389A (en) | Chromosome banding by monoclonal antibodies to nuclear proteins | |
| AU1979283A (en) | Nitroglycerine solution |